Inventor
GAUDERNACK GUSTAV
NO21 patents
⚠️ This page may combine multiple inventors who share the name “GAUDERNACK GUSTAV”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GEMVAX AS
7 patentsUS6759046B1Jul 6, 2004
Peptides
GEMVAX AS74 citations96
US7794723B2Sep 14, 2010
Antigenic peptides derived from telomerase
GEMVAX AS47 citations95
US6861057B2Mar 1, 2005
Immunogenic β-amyloid peptide
GEMVAX AS36 citations92
US7192927B2Mar 20, 2007
Peptides
GEMVAX AS20 citations90
US7078416B2Jul 18, 2006
Polypeptides
GEMVAX AS21 citations90
US7863244B2Jan 4, 2011
Peptides
GEMVAX AS9 citations82
US7375117B2May 20, 2008
Polypeptides
GEMVAX AS7 citations69
ULTIMOVACS AS
5 patentsUS10383928B2Aug 20, 2019
Telomerase polypeptide vaccine for treating cancer
ULTIMOVACS AS4 citations79
US12168045B2Dec 17, 2024
Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer
ULTIMOVACS AS0 citations60
US11419927B2Aug 23, 2022
Vaccine in combination with an immune checkpoint inhibitor for use in treating cancer
ULTIMOVACS AS0 citations60
US11998595B2Jun 4, 2024
Telomerase polypeptide vaccine for treating cancer
ULTIMOVACS AS0 citations58
US11529403B2Dec 20, 2022
Telomerase polypeptide vaccine for treating cancer
ULTIMOVACS AS0 citations58